We evaluated phenotypic markers in full-genome sequences of avian influenza isolates to identify avian strains with increased potential for transmission and pathogenicity in mammals. Of 149 markers examined, 67 were positive in the consensus sequences from 206 avian isolates. Analysis of deep sequencing data in a subset of 24 isolates revealed that 344 subpopulations occurred at marker positions. Markers in subpopulations were significantly more likely to be negative (258/344) than positive (86/344), but nearly all of the marker-positive subpopulations (78/86) were associated with marker-negative consensus sequences. Our analysis revealed significant variation in important markers among avian isolates, and showed that consensus sequences do not fully convey an isolate's potential for increased transmissibility and pathogenicity in mammals.
Introduction
The recent emergence of highly pathogenic avian influenza (HPAI) H5N1 and pandemic H1N1 (H1N1pdm) graphically shows that genotypic and phenotypic changes in animal influenza viruses will continue to produce new human pathogens [1, 2] . If we are to recognize and prepare for new emerging viruses, we must identify genotypic and phenotypic markers that indicate which animal viruses are most transmissible and pathogenic to humans. This is a formidable challenge given the tremendous genetic diversity of viruses circulating among birds and mammals in nature [3, 4] , and since laboratory phenotyping for even a single amino acid change can involve the use of wild-type and reverse genetic variants [5] [6] [7] , culture in multiple cell lines [8] , and experimental infections in rodents [8] [9] [10] , guinea pigs [11, 12] , and ferrets [10, 13, 14] .
Enhanced surveillance [15] , coupled with advances in sequencing and bioinformatics [16] , gives us the ability to develop hypotheses about which strains and subtypes pose the greatest risk and deserve further scrutiny as potential human pathogens. An important step in this process is to determine whether or not phenotypic markers deduced from sequence data are useful for assessing risk [11, [17] [18] [19] . Phenotypic markers are amino acid substitutions that are suggested to alter pathogenicity and host tropism of influenza viruses to increase their likelihood to be transmitted from an avian to a mammalian host and cause disease. Table 1 Phenotypic markers (n = 149) reported from influenza A viruses that were analyzed in this study of 206 full genome sequences. The H5 numbering system was used to identify nucleotide positions in our analysis. Markers were identified by review of existing literature. Asterisks refer to positive markers in the consensus sequence (*) or subpopulation (**). H/L56Y Increased virulence in mammals ** [44, 85] In this study, we approached the question of whether molecular markers for increased pathogenicity and transmissibility/host tropism in mammals are useful to identify avian influenza viruses of public health importance. We identified potentially relevant phenotypic markers from the literature, and analyzed consensus and deep sequence data from viruses isolated from wild birds and the environment in California. The goal of our study was to answer the following questions: what molecular markers have been identified with potential importance for increased pathogenicity and transmissibility in mammals? Are these molecular markers present in the consensus sequence of isolates in California (2005-2010)? Are positive markers in the consensus sequence of Californian isolates associated with particular hemagglutinin (HA) subtypes? What viral subpopulations can be identified at the amino acid sites that contain the known molecular markers?
Materials and methods

Virus isolation and sequencing
Full influenza virus genome sequences were obtained from 206 viruses isolated from wild birds and environmental samples collected in California from 2005 to 2010. Viruses were isolated at the University of California, Davis, by inoculation of embryonated chicken eggs [20, 21] . Full genome sequencing was performed at the J. Craig Venter Institute (JCVI) and all generated sequences were assigned GenBank accession numbers (Supplementary Table 1 ). Isolates with mixed infections (more than a single HA or neuraminidase (NA) subtype) were not included in this analysis, nor were isolates sharing >99.8% sequence identity across all 8 segments (i.e. identical viruses).
Supplementary material related to this article can be found, in the online version, at http://dx.doi.org/10.1016/ j.cimid.2013.06.003.
Next generation sequencing (NGS) (454, Illumina) performed at JCVI was designed to provide 200× coverage of the genome [16] . Consensus sequences were determined by identifying the predominant base among all reads at a given nucleotide site. Thus, the consensus sequences deposited in GenBank reflect bases occurring in the majority of the reads for any given nucleotide site. Although NGS was primarily used to accomplish high throughput consensus sequencing, the level of coverage also yielded deep sequencing analysis data. A subset of virus isolates (n = 24) was examined for single nucleotide polymorphisms (SNPs) to identify subpopulation variants possessing different amino acids at marker positions than the consensus sequence.
Selection and analysis of phenotypic markers
We performed a literature search to compile an inventory of amino acid mutations reported to be associated with changes in host tropism or increased pathogenicity in mammals, and identified 149 markers for use in this analysis (Table 1) Consensus sequence data for the 206 isolates was analyzed using tools provided on the IRD website (data was obtained from the NIAID IRD online through the website at http://www.fludb.org) [22] . Amino acids at the 149 marker positions were identified using the "Identify Point Mutations in proteins" tool on the IRD website, downloaded and processed in Microsoft Excel. The challenge presented by the different numbering systems for HA subtypes was overcome by preparing an alignment of all HA subtypes and using this tool to determine nucleotide positions relative to the H5 numbering system (Fig. 1) . Each marker site was classified as positive or negative depending on whether or not the observed amino acid at that site matched the reported marker phenotype. For example, the presence of Fig. 1 . Alignment (Clustal Omega) of influenza A virus mature HA sequences (without the H0 signal peptide) from of H1 to H14 subtypes. The isolates are named as "Subtype Country Year GenBank Accession#". H3 subtype is marked in red and H5 subtype is marked in blue. Highly, moderately and weakly conserved residues are highlighted in black, dark grey, and light grey, respectively. Phenotypic markers for increased virulence or transmissibility (Table 1) are highlighted in red. isoleucine (I) at amino acid position 28 in the PB2 protein would be classified as positive for the marker PB2 M28I (first marker in Table 1 ). If methionine (M) or any other amino acid was observed at position 28, the marker was classified as negative. The frequencies of positive and negative markers were calculated for each HA subtype, and we tested the null hypothesis that markers were equally distributed among HA subtypes using Fisher's exact test (GraphPad Prism, GraphPad Software, La Jolla CA, USA).
Subpopulation analysis
The CLC Bio find variations tool was used to examine deep sequencing data and identify viral subpopulations. SNPs were defined as subpopulations when >5% of total reads at any given site differed from the consensus sequence. Output for SNPs included nucleotide position and the number of A (Adenine), T (Thymine), G (Guanine), C (Cytosine) calls or reads, at that site. The corresponding amino acid position for each SNP was determined by visual inspection to see if subpopulations occurred at marker sites. Each subpopulation at a marker site was classified as positive or negative as described above for consensus sequences. We compared subpopulation phenotypes with consensus sequence phenotypes and categorized results into one of 4 outcomes: (1) phenotypic marker was positive in the consensus sequence, but negative in the subpopulation; (2) marker was positive in the subpopulation, but negative in the consensus sequence; (3) marker was negative in the subpopulation and the consensus sequence; and (4) marker was positive in both subpopulation and consensus sequence. Although we focused on identifying subpopulations that altered the phenotype represented in the consensus sequence, we examined the entire data set for the presence of SNPs (=subpopulations) at any site in the genome.
Results and discussion
Surveillance of avian influenza virus (AIV) in wild birds is crucial to track the emergence, evolution and spread of viruses, and recent efforts have yielded a flood of prevalence and sequence data [23] . However, a key challenge remains: can we use genotype data to identify and predict viruses that pose the greatest threat to human and animal health? The advent of NGS and online phenotyping tools allow researchers to begin addressing this challenge by mining the vast array of sequence data that is accumulating through ongoing surveillance. This study demonstrates that approach, using the IRD amino acid phenotyping tool to identify and characterize phenotypic markers for increased pathogenicity and host tropism in mammals to identify AIV of public health significance.
Our first question was which molecular markers are useful for detecting increased pathogenicity and transmissibility in mammals, and are these markers present in the consensus sequence of isolates in California (2005) (2006) (2007) (2008) (2009) (2010) The phenotypic markers identified in our isolates were not evenly distributed across influenza segments. The number of positive markers per segment were: PB2 (17/34, 50%), PB1 (7/16, 43.75%), PB1-F2 (1/1, 100%), HA (20/40, 50%), M1 (3/6, 50%) and M2 (1/2, 50%), PA (6/18, 33.3%), NP (3/10, 30%) and NS1 (5/16, 31.3%). No positive markers were detected on the segments encoding the NA (0/2) and NEP/NS2 (0/4).
We rejected the null hypothesis that positive markers were equally distributed across HA subtypes ( Table 2) . Thirty-three (33) of the 63 positive markers were significantly (P ≤ 0.05) over-or under-represented in particular subtypes, and these differences were highly significant (P ≤ 0.001) for 21 of the markers. The 33 markers that varied significantly among HA subtypes were found primarily in the HA (n = 18) and PB2 (n = 7) segments, and to a much lesser extent in PB1 (n = 2), PB1-F2 (n = 1), NS1 (n = 2), PA (n = 2), and NP (n = 1). None of the phenotypic markers identified in the NA, M1 and M2 proteins showed any significant association with HA subtype.
We were interested to see whether HA subtypes that were found in previous pandemic human influenza strains (H1, H2 and H3) [24, 25] , or that have been reported to cause zoonotic infections (H5, H7 and H9) [26] , had more positive markers than other HA subtypes. Positive markers occurred significantly less often in subtypes H6, H7, H10 and H11 compared to subtypes H1, H2, H3 and H5. We were somewhat surprised by the paucity of markers in H7 sequences. The recent emergence of H7N9 in humans in China (Gao et al., 2013) provided an opportunity to compare markers with our California H7 sequences. Phenotypic marker analysis revealed 6 positive markers (PB2 E/D627K/N, PB1 R207K, PB1 I368V, PB1 H436Y, PA V100A, HA Q222L) that were negative in all Californian isolates analyzed in this study. Thus, the reduced number of markers in our H7 sequences appears to reflect their reduced risk relative to emerging H7N9 variants in China. Surprisingly, positive markers occurred significantly more frequently in subtype H4 than any other subtypes except for H1 and H2. This subtype has not been associated with seasonal or pandemic infections in humans, but it has been occasionally isolated from mammals including pigs, horses, rodents and marine mammals [27] . These results, coupled with the fact the H4 subtype can support a highly pathogenic phenotype [28] suggest that H4 viruses deserve increased attention as potential threats.
We found the mean number of positive markers per isolate to vary significantly among HA subtypes. Across all positive markers observed in our study (n = 63), the highest mean number of positive markers for each isolate in a subtype was found in H4, followed by H1 and H2 (Table 3A) . When considering only those markers that increase virus binding to ˛2,6 linked sialic acid receptors (n = 14), H1 showed the highest mean number, followed by H5 and H3 (Table 3B ). This result suggests that HA subtypes most commonly associated with influenza infections Table 2 Distribution of phenotypic markers that varied significantly between HA subtypes. Upward and downward arrows indicate that a marker was significantly more or less common, respectively, in that HA subtype when compared against all other subtypes combined. Numbers of virus isolates for each subtype are indicated in brackets. Frequencies of phenotypic markers for each subtype were compared according to Fisher's exact test (↑↑↑, ↓↓↓ p ≤ 0.001, ↑↑, ↓↓ p ≤ 0.01, ↑, ↓ p ≤ 0.05, -, not significant) (aa, amino acid. For aa: A, Alanine; D, Aspartic Acid; E, Glutamic Acid; F, Phenylalanine; G, Glycine; H, Histidine; I, Isoleucine; K, Lysine; L, Leucine; M, Methionine; N, Asparagine; P, Proline; Q, Glutamine; R, Arginine; S, Serine; T, Threonine; V, Valine; Y, Tyrosine).
Gene aa mutation H1 (12) H2 (6) H3 (13) H4 (29) H5 (22) H6 (71) H7 (8) H8 (4) H10 (22) H11 (14) H12 (5) PB2
in mammals have an increased number of transmissibility markers compared to other, predominantly avian HA subtypes. Alternatively, our selection of markers may be biased towards these HA subtypes because these markers were primarily found in subtypes isolated from mammals. In some HA subtypes there was a strong contrast between the total occurrence of a positive marker per subtype and the mean number of positive markers per isolate. For example, H4 had 38 positive markers yet the mean per isolate was only 25.58 ± 1.52. This reflects the fact that many positive markers occurred only in one or a small number of isolates and were absent in all the other isolates. One intriguing, but untested, explanation for this pattern is that isolates with marker-positive phenotypes may be at a selective disadvantage in birds (thus their low frequency), but have a greater potential for successfully infecting mammals. The idea that certain strains can more easily infect mammals was further addressed by answering this question: were viral subpopulations present at marker sites in our isolates? Analysis of deep sequencing data for 24 isolates revealed a total of 11,088 SNPs, of which 344 occurred at marker positions. Results for A/mallard/California/6768/2009 (H1N1) are shown in Table 4 , and described below to facilitate interpretation. Data for all 24 isolates are shown in Supplementary Table   3 . For the isolate in Table 4 , 153 SNPs were present in over 5% of nucleotide reads, and 5 of these SNPs were present at phenotypic marker positions. One of these 5 SNPs at marker positions caused a non-synonymous amino acid substitution at position 271 of the PB2 protein, changing the threonine (T) found in the consensus amino acid sequence to an alanine (A) in a viral subpopulation. PB2 T217A is a reported human host marker ( Table 1) . The subpopulation presents with a guanine (G) in 6.7% of nucleotide reads, constituting the viral subpopulation and causing the observed amino acid substitution, while 93.3% of nucleotides present with an adenine (A) in the consensus sequence. At position 127 in the NS1 protein, the positive marker NS1 127N is found in the consensus sequence (C in 94.2% nucleotide reads), whereas a viral subpopulation (A in 5.8% nucleotide reads) shows a lysine (K) at this position, rendering the subpopulation negative for this marker. A positive marker at this position would have suggested increased virulence in mammals (Table 1) . Two synonymous changes occurred in subpopulations at PB2 199 and NP 16 (both are reported human host markers (Table 1) ), but both consensus sequence and subpopulation are negative for a phenotypic marker at this position. One non-synonymous change occurred at position 15 of the M1 protein (a Y at this aa position is associated with Table 3 Occurrence and frequency of all 63 positive phenotypic markers observed in this study (A), and of 14 positive markers for increased virus binding to ␣2-6 linked sialic acid receptors (B). Numbers of virus isolates for each subtype are indicated in brackets.
H1 (12) H2 (6) H3 (13) H4 (29) H5 (22) H6 (71) H7 (8) H8 (4) H10 (22) H11 (14) H12 (5 3.00 ± 0.0 3.4 ± 0.7 2.7 ± 0.5 3.7 ± 0.5 2.00 ± 0.0 1.00 ± 0.0 2.00 ± 0.0 0 ± 0 3.1 ± 0.3 2.2 ± 0.5 Table 4 Example Deep sequencing results for all 24 isolates are summarized in Table 5 , and provided in full in Supplementary  Table 3, and Table 1 contains information which positive markers were positive in subpopulations. Comparison of subpopulation phenotypes with consensus sequence phenotypes yielded these results: (1) 61 markers were positive in the consensus sequence, but negative in the subpopulation; (2) 78 markers were positive in the subpopulation, but negative in the consensus sequence; (3) 197 markers were negative in both the subpopulation and the consensus sequences, and (4) 8 markers were positive in both subpopulation and consensus sequences. Overall, subpopulations present at marker positions were significantly more likely to be negative (258/344) than positive (86/344) . Nearly all of the marker-positive subpopulations (78/86) were associated with consensus sequences that were marker-negative. Likewise, nearly all of the marker-positive consensus sequences were associated with negative subpopulations (61/69). Our analysis revealed significant variation in important phenotypic markers among avian isolates, and showed that consensus sequences do not fully convey an isolate's potential for increased transmissibility and pathogenicity in mammals.
Although our analysis revealed significant variation in the occurrence and frequency of important markers among isolates and HA subtypes, functional studies in vitro and in vivo are needed to confirm the significance of these changes, as conflicting results have been obtained in the past. For example, a great body of evidence suggests PB2-627 as a determinant for increased mammalian pathogenicity and host tropism (see Table 1 ), but other studies fail to report these findings [29] [30] [31] [32] .
Viruses analyzed in our current study were obtained after a single passage in embryonated chicken eggs to minimize potential changes caused by adaptation to chicken eggs [33] . Future experiments will include passage of candidate strains in avian and mammalian systems to evaluate the relative fitness of strains possessing specific marker phenotypes that differ between consensus and subpopulation sequences. The occurrence of a given marker is expected to change under selective pressure, such as that seen for viruses exposed to the NA inhibitor oseltamivir [34, 35] . Amino acid mutations associated with drug resistance were identified in subpopulations of influenza patients in the absence of drug-associated selection pressure (before oseltamivir treatment) and became more dominant in the patient after oseltamivir therapy, and in virus passage in mammalian cells [34] . If a given positive marker in our isolates significantly enhances transmission from birds to mammals, we would expect its frequency to increase after passage in mammalian cells, possibly becoming dominant in the consensus sequence. Furthermore, passage of the same isolate in chicken eggs may be expected to result in decreased frequency or total loss of the positive marker.
Conclusion
Our analysis revealed significant variation in important phenotypic markers among avian isolates, and showed that consensus sequences do not fully convey an isolate's potential for increased transmissibility and pathogenicity in mammals. Analysis of markers in emerging new viruses such as H7N9 in humans, coupled with controlled laboratory experiments as described above, will help reveal which markers are the most relevant for identifying viruses that bear a high risk for humans and animals [36] . Since virus culture inevitably introduces artificial changes in the viral genome, it is critical that we develop the ability to generate full genome sequences from samples without culture in cells. This will ensure that molecular markers investigated in the laboratory accurately reflect genotypes occurring in nature.
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